Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$2.26B |
| 2 |
Carrier Global
CARR
|
+$1.12B |
| 3 |
Chevron
CVX
|
+$922M |
| 4 |
Comcast
CMCSA
|
+$920M |
| 5 |
Philip Morris
PM
|
+$876M |
Top Sells
| 1 |
Alibaba
BABA
|
+$5.5B |
| 2 |
Netflix
NFLX
|
+$1.73B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.61B |
| 4 |
TransDigm Group
TDG
|
+$850M |
| 5 |
Abbott
ABT
|
+$773M |
Sector Composition
| 1 | Healthcare | 20.46% |
| 2 | Technology | 19.55% |
| 3 | Communication Services | 14.69% |
| 4 | Consumer Discretionary | 11.55% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Hormel Foods
HRL
$13.8B
| $216M | 0.07% |
4,482,854
-3,849,952
| -46% | -$186M |
|
202
Schlumberger
SLB
$53.1B
| $216M | 0.07% |
11,742,809
-8,391,924
| -42% | -$154M |
|
203
Enbridge
ENB
$107B
| $212M | 0.07% |
6,984,941
+4,613,002
| +194% | +$140M |
|
204
IAC Inc
IAC
$2.89B
| $211M | 0.07% |
3,648,385
-307
| -0% | -$17.7K |
|
205
Xcel Energy
XEL
$43.4B
| $211M | 0.07% |
3,371,637
+61
| +0% | +$3.81K |
|
206
Frontdoor
FTDR
$4.83B
| $203M | 0.06% |
4,579,200
-998,374
| -18% | -$44.3M |
|
207
Prologis
PLD
$107B
| $200M | 0.06% |
2,146,547
+1,219,040
| +131% | +$114M |
|
|
SIVB
208
DELISTED
SVB Financial Group
SIVB
| $198M | 0.06% |
916,624
-634,504
| -41% | -$137M |
|
|
PLAN
209
DELISTED
Anaplan, Inc.
PLAN
| $196M | 0.06% |
4,326,218
+2,855,618
| +194% | +$129M |
|
210
Nutrien
NTR
$27.7B
| $195M | 0.06% |
6,086,275
+29,811
| +0.5% | +$957K |
|
211
Intuit
INTU
$180B
| $194M | 0.06% |
655,268
-248
| -0% | -$73.5K |
|
212
Madrigal Pharmaceuticals
MDGL
$9.63B
| $192M | 0.06% |
1,697,119
| – | – |
|
213
CenterPoint Energy
CNP
$25B
| $190M | 0.06% |
+10,189,288
| New | +$190M |
|
214
GSK
GSK
$82.2B
| $189M | 0.06% |
3,703,916
+3,703,757
| +2,329,407% | +$189M |
|
215
Paycom
PAYC
$12.5B
| $186M | 0.06% |
600,916
+66
| +0% | +$20.4K |
|
216
Burlington
BURL
$16.8B
| $184M | 0.06% |
934,801
+478,654
| +105% | +$94.3M |
|
|
GTM
217
ZoomInfo Technologies
GTM
$3.72B
| $184M | 0.06% |
+3,600,050
| New | +$184M |
|
218
Micron Technology
MU
$176B
| $179M | 0.06% |
3,471,708
-608,290
| -15% | -$31.3M |
|
219
Yeti Holdings
YETI
$2.88B
| $175M | 0.06% |
4,093,142
+436,393
| +12% | +$18.6M |
|
220
New York Times
NYT
$9.59B
| $175M | 0.06% |
4,154,652
-150,312
| -3% | -$6.32M |
|
221
Visa
V
$659B
| $172M | 0.05% |
890,532
-497,033
| -36% | -$96M |
|
222
Pfizer
PFE
$136B
| $166M | 0.05% |
5,347,031
+3,762,891
| +238% | +$117M |
|
|
AVLR
223
DELISTED
Avalara, Inc.
AVLR
| $165M | 0.05% |
1,239,896
+511,313
| +70% | +$68.1M |
|
224
Equity Residential
EQR
$25.4B
| $164M | 0.05% |
+2,789,740
| New | +$164M |
|
225
iRhythm Technologies
IRTC
$5.78B
| $163M | 0.05% |
1,408,868
+54,718
| +4% | +$6.34M |
|